Literature DB >> 8865034

MRI of elephantiasis neuromatosa.

T F Münte, M Matzke, S Johannes, B Dietrich, R Dengler.   

Abstract

Entities:  

Mesh:

Year:  1996        PMID: 8865034     DOI: 10.1007/bf00900955

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  7 in total

1.  Neurofibromatosis: unusual lymphangiographic findings.

Authors:  J M Preston; R J Starshak; H W Oechler
Journal:  AJR Am J Roentgenol       Date:  1979-03       Impact factor: 3.959

2.  Elephantiasis neuromatosa; a manifestation of von Recklinghausen's disease.

Authors:  R J WESTCOTT; L V ACKERMAN
Journal:  Arch Derm Syphilol       Date:  1947-02

3.  Clinical manifestations of congenital neurofibromatosis.

Authors:  H R McCARROLL
Journal:  J Bone Joint Surg Am       Date:  1950-07       Impact factor: 5.284

4.  Plexiform neurofibromatosis: a difficult surgical problem.

Authors:  L A Kuo; R S Kuo
Journal:  Aust N Z J Surg       Date:  1990-09

5.  The value of computed tomography in elephantiasis neuromatosa.

Authors:  P D Birch; A M Davies
Journal:  Br J Radiol       Date:  1988-01       Impact factor: 3.039

6.  Neurofibromatosis, gigantism and subperiosteal haematoma. Report of two children with extensive subperiosteal bone formation.

Authors:  L Kullmann; H W Wouters
Journal:  J Bone Joint Surg Br       Date:  1972-02

7.  Elephantiasis neuromatosa. A light, immunohistochemical and electron microscopic study.

Authors:  S Holck; S Medgyesi; E Darre; M Lassen
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984
  7 in total
  1 in total

1.  Giant elephantiasis neuromatosa in the setting of neurofibromatosis type 1: A case report.

Authors:  Giovanni Ponti; Giovanni Pellacani; Davide Martorana; Victor Desmond Mandel; Pietro Loschi; Annamaria Pollio; Annarita Pecchi; Cristina Dealis; Stefania Seidenari; Aldo Tomasi
Journal:  Oncol Lett       Date:  2016-04-19       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.